发明名称 SUBSTITUTED MORPHOLINE COMPOUND FOR TREATING CENTRAL NERVOUS SYSTEM DISORDER
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a substituted morpholine compound for treating central nervous system disorders. <P>SOLUTION: The compound expressed by formula (I) or its pharmaceutically permissible salts are provided. In the formula, A expresses O or S; X expresses a heterocyclic ring; R<SP>1</SP>to R<SP>5</SP>express each H, a 1-6C alkyl, an aryl, a 3-8C cycloalkyl, a 1-6C alkenyl, a 5-8C cycloalkenyl, a (CH<SB>2</SB>)<SB>n</SB>-3-8C cycloalkyl, a 1-6C alkoxy, an O-aryl or the like; * expresses a first chiral center; Ð expresses a second chiral center. <P>COPYRIGHT: (C)2008,JPO&INPIT</p>
申请公布号 JP2008019267(A) 申请公布日期 2008.01.31
申请号 JP20070233201 申请日期 2007.09.07
申请人 WARNER-LAMBERT CO LLC 发明人 BARTA NANCY SUE;GLASE SHELLY ANN;GRAY DAVID LAWRENCE FIRMAN;REICHARD GREGORY ADAM;SIMONS LLOYD JEROME;XU WENJIAN
分类号 C07D265/30;A61K31/537;A61K31/5375;A61K31/5377;A61P1/14;A61P3/04;A61P7/10;A61P7/12;A61P9/10;A61P11/16;A61P15/08;A61P21/00;A61P25/00;A61P25/02;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/26;A61P25/28;A61P25/30;A61P25/32;A61P25/34;A61P25/36;A61P27/02;A61P27/06;A61P43/00;C07D413/02;C07D413/06;C07D413/12;C07D413/14;C07D417/06;C07D417/12 主分类号 C07D265/30
代理机构 代理人
主权项
地址